Rubicon Technology, Inc. (NASDAQ: RBCN), International Flavors & Fragrances Inc. (NYSE: IFF), Makemytrip Limited (NASDAQ: MMYT), Rovi Corp. (NASDAQ: ROVI), Medicis Pharmaceuticals (NYSE: MRX) and Accretive Health, Inc. (NYSE: AH) ratings and price target changes and reiterations.
Rubicon Technology, Inc. (RBCN) was downgraded by Avian from a “Positive” rating to a “Neutral” rating.
International Flavors & Fragrances Inc. (IFF) had its price target lowered by RBC Capital from $63.00 to $56.00. They have a “Sector Perform” rating on the company.
Makemytrip Limited (MMYT) had its price target raised by Maxim Group from $25.00 to $39.00. They have a “Buy” rating on the company.
Rovi Corp. (ROVI) had its price target lowered by Canaccord Genuity from $71.00 to $63.00. They have a “Buy” rating on the company.
Medicis Pharmaceuticals (MRX) had its price target lowered by Piper Jaffray (NYSE:PJC) to $43.00.
Oppenheimer reiterated its "Market Perform" rating on Accretive Health, Inc. (AH).
Thursday, November 10, 2011
Rubicon (RBCN) (IFF) (MMYT) (ROVI) (MRX) (AH) Ratings, Price Targets
Labels:
Piper Jaffray,
Rubicon Technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment